FIELD: medicine, dermatology. SUBSTANCE: invention describes application of one or more acid alkylfumarates of the general formula (I): where R means C1-C5-alkyl mixed if necessary with dialkyl-fumarates of the formula (II): and, possibly, with conventional pharmaceutical accessory agents and carriers for preparing pharmaceutical preparative form as microtablets or microgranules. Proposed acid fumarates are used for treatment of psoriasis, psoriatic arthritis, neurodermitis and chronic cicatrizing enteritis. Microtablets and microgranules are distributed in stomach uniformly. EFFECT: improved and valuable medicinal properties of compounds. 7 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
FUMARIC ACID-BASE MICROTABLETS | 1999 |
|
RU2210366C2 |
APPLICATION OF DERIVATIVES OF FUMARIC ACID IN TRANSPLANTATION MEDICINE | 1999 |
|
RU2210364C2 |
APPLICATION OF FUMARIC ACID DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | 2000 |
|
RU2218918C1 |
APPLICATION OF FUMARIC ACID DERIVATIVES | 1998 |
|
RU2197963C2 |
DERIVATIVES OF FUMARIC ACID AS NF-kappaB INHIBITOR | 2002 |
|
RU2282440C2 |
USING FUMARIC ACID DERIVATIVES FOR TREATING CARDIAC FAILURE, MYOCARDIAL INFARCTION AND ANGINA | 2007 |
|
RU2459621C2 |
USING DERIVATIVES OF FUMARIC ACID IN TREATMENT OF CARDIAC INSUFFICIENCY AND ASTHMA | 2004 |
|
RU2313339C2 |
FUMARIC ACID AMIDES | 2002 |
|
RU2290946C2 |
DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE | 2019 |
|
RU2742745C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE ESTERS OF FUMARIC ACID IN A DECOMPOSABLE MATRIX | 2010 |
|
RU2743637C2 |
Authors
Dates
2003-01-27—Published
1998-12-08—Filed